Wilfried Dalemans is Chief Technical Officer at TiGenix, Belgium. He is responsible for the global technical operations of the company, encompassing coordination of product development and life-cycle in R&D and Industrialization, and overseeing the clinical and commercial manufacturing operations of the company. Before joining TiGenix, Wilfried Dalemans held several senior management positions at GSK Biologicals, Belgium, both in regulatory affairs and in research and development. Prior to joining GSK, he worked at Transgène, France, where he was responsible for the cystic fibrosis research program. Wilfried Dalemans holds a Masters degree in Zoology from the University of Antwerpen (Belgium) and a PhD in Molecular Biology from the Universities of Hasselt and Leuven
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)